bioAffinity Technologies, Inc. Income Statement

Income Statement Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -1.00M0.00M2.53M9.36M
Cost of Revenue 0.00M1.74M5.98M
Gross Profit -1.00M0.00M0.79M3.38M
Operating items
Depreciation & Amortization - Total 0.01M0.23M0.16M
Research & Development 1.01M1.40M1.47M1.46M
Selling, General & Administrative 1.07M2.48M6.79M9.94M
Other Operating Expenses 0.13M0.12M2.01M6.75M
Operating Expenses 2.21M4.02M10.51M18.32M
Operating Income -2.21M-4.01M-7.97M-8.95M
EBIT -2.21M-4.01M-7.97M-8.95M
Non-operating items
Interest & Investment Income 0.00M0.05M0.12M0.02M
Other Non Operating Income 0.24M0.21M0.00M0.01M
Non Operating Income -4.14M0.06M-0.07M
Net income details
EBT -6.32M-8.15M-7.92M-9.03M
Tax Provisions 0.00M0.00M0.02M0.01M
Profit After Tax -6.33M-8.15M-7.94M-9.04M
Income from Continuing Operations -6.33M-8.15M-7.94M-9.04M
Consolidated Net Income -6.33M-8.15M-7.94M-9.04M
Income towards Parent Company -6.33M-8.15M-7.94M-9.04M
Net Income towards Common Stockholders -6.33M-8.15M-7.94M-9.04M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.14M0.28M0.32M0.52M
Shares Outstanding (Diluted Average) 4.50M8.75M12.13M
EBITDA -2.21M-4.00M-7.74M-8.79M